Botulinum Toxin Type A Therapy in Migraine: Preclinical and Clinical Trials

BACKGROUND: Botulinum toxin type A (BTX-A) has been reported to be effective for the therapy for migraine. The purpose of this study was to investigate the effect of BTX-A on the immunoreactive levels of calcitonin gene-related peptide (CGRP) and substance P (SP) in the jugular plasma and medulla ob...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Yu-Feng, Zhang, Yi, Zhao, Peng, Yan, Wen-Jun, Kong, Xiang-Pan, Fan, Lin-Lan, Hou, Yi-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950781/
https://www.ncbi.nlm.nih.gov/pubmed/24693369
http://dx.doi.org/10.5812/ircmj.7704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3950781/
https://www.ncbi.nlm.nih.gov/pubmed/24693369
http://dx.doi.org/10.5812/ircmj.7704

Ejemplares similares